Integra LifeSciences (NASDAQ:IART) Vs. ABT, MDT, ISRG, SYK, BDX, EW, BSX, IDXX, BAX, and DXCM
Should you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), Baxter International (BAX), and DexCom (DXCM). These companies are all part of the "health care equipment" industry.
Integra LifeSciences vs.
Integra LifeSciences (NASDAQ:IART) and Medtronic (NYSE:MDT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment.
Medtronic has a net margin of 14.80% compared to Integra LifeSciences' net margin of 14.19%. Integra LifeSciences' return on equity of 17.33% beat Medtronic's return on equity.
Integra LifeSciences presently has a consensus target price of $76.50, indicating a potential upside of 13.77%. Medtronic has a consensus target price of $131.62, indicating a potential upside of 26.30%. Given Medtronic's stronger consensus rating and higher probable upside, analysts plainly believe Medtronic is more favorable than Integra LifeSciences.
90.2% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 79.0% of Medtronic shares are owned by institutional investors. 4.2% of Integra LifeSciences shares are owned by insiders. Comparatively, 0.5% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Integra LifeSciences has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500.
Medtronic received 1134 more outperform votes than Integra LifeSciences when rated by MarketBeat users. Likewise, 78.99% of users gave Medtronic an outperform vote while only 61.71% of users gave Integra LifeSciences an outperform vote.
Medtronic has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.
In the previous week, Medtronic had 8 more articles in the media than Integra LifeSciences. MarketBeat recorded 15 mentions for Medtronic and 7 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 0.46 beat Medtronic's score of -0.21 indicating that Integra LifeSciences is being referred to more favorably in the media.
Summary
Medtronic beats Integra LifeSciences on 13 of the 18 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Integra LifeSciences (NASDAQ:IART) vs. Its Competitors
Integra LifeSciences Competitors List
